TLPH Q2 2021 Earnings — Talphera, Inc. Revenue & Financial Results | Market Cap Arena

TLPHTalphera, Inc.

$18M

Q2 2021 Earnings

Healthcare Drug Manufacturers - Specialty & Generic

Income Statement

Revenue

$443,000-84.8% YoY

Gross Profit

-$597,000-134.8% margin

Operating Income

-$10M-2260.7% margin

Net Income

-$10M-2223.7% margin

EPS (Diluted)

$-1.65

QoQ Revenue Growth

-13.3%

Cash Flow

Operating Cash Flow

-$8M

Free Cash Flow

-$10M

Stock-Based Comp.

$1M

Balance Sheet

Total Assets

$80M

Total Liabilities

$116M

Stockholders' Equity

-$36M

Cash & Equivalents

$26M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$443,000	$3M	-84.8%
Gross Profit	-$597,000	$2M	-138.4%
Operating Income	-$10M	-$7M	-46.5%
Net Income	-$10M	-$7M	-49.1%